Innovation in heart rhythm management

We are developing innovative therapies to transform the way atrial fibrillation is treated, from hospital to home.

Our focus

Innovative therapies designed to restore normal heart rhythm — from hospital to home

Hospital-based innovation

We are developing rapid, effective therapies for safe cardioversion during inpatient and outpatient hospital care.

At-home empowerment

Next-generation solutions to let patients self-administer treatment  in the comfort of home.

Driven by science

We are guided by clinical insight, rigorous research, and a commitment to improving patient outcomes.

Our team

Experts in heart rhythm care

United by a mission to improve lives, our multidisciplinary team develops innovative therapies for atrial fibrillation.

Miguel Guzman

Head CMC

Jean Maupas

Data Management

Julie Rogers

Clinical Manager

Dr. Myles Greenberg

CEO

Dr. Luiz Belardinelli

CMO

Carol Manchester, MBA

CFO

Carlos Schuler, PhD,

CTO

Narsi Rangachari, M.Pharm.

CBO

Leo Santana

Controller

Dawn Parsell

Head Regulatory

Sarah McNulty

Regulatory Ops

Kate Ecklund

Head Clnical Ops
Board of Directors

Guiding our vision with experience and leadership

Miguel Guzman

Head CMC

Jean Maupas

Data Management

Julie Rogers

Clinical Manager

Dr. Myles Greenberg

CEO
Investors
Contact

Connect with us to learn more

We’d love to hear from you — whether you’re a patient, clinician, partner, or investor, our team is ready to connect.

Contact us